AVITA Medical, Inc. (RCEL)

12.72 +0.71 (+5.91%) USD  |  NASDAQ  |  Oct 02, 16:00
12.66 -0.06 (-0.51%) After-Hours: 20:00
More

AVITA Medical EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for RCEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to 2022. Start Trial.
Date Value
February 24, 2023 --
Date Value
March 01, 2022 --

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Iovance Biotherapeutics, Inc. --
Amgen, Inc. Upgrade
Editas Medicine, Inc. --
Arcus Biosciences, Inc. Upgrade